PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS IN A CASE OF PYRUVATE KINASE DEFICIENCY
Main Article Content
Abstract
Background: Pyruvate kinase deficiency (PKD) is an autosomal recessive genetic disorder caused by mutations in the PKLR gene. Mutations in this gene are a common cause of chronic hemolytic anemia. People with this disorder suffer from reduced quality of life and economic burden. Preimplantation genetic testing for monogenic disorders (PGT-M) is an option for families carrying a genetic mutation to select embryos with out the mutation to transfer to have healthy babies. Case report: A couple whose daughter was diagnosed with hemolytic anemia disease wanted to undergo PGT-M. Molecular biological techniques including MLPA, Sanger sequencing, NGS, and genetic linkage analysis were used to identify the gene mutation in the family as well as identify embryos that did not carry the gene mutation. Results: Two mutations c.941T>C (p.Ile314Thr) and deletion from exon 3 to exon 9 in the PKLR gene were detected in this family, which are associated with pyruvate kinase deficiency. Of the four biopsied embryos for preimplantation genetic testing, only two embryos without chromosomal aneuploidy were did PGT-M testing futher. As a result, one embryo was a compound heterozygote, one embryo was free with both mutations in the PKLR gene and was transferred into the mother's uterus. Conclusions: Accurate detection of pathogenic mutations is important in counseling and performing PGT-M testing. Combining direct analysis with genetic linkage analysis increases the reliability of PGT-M results. Successfully developing a PGT-M procedure for mutations in the PKLR gene helps the patient's family have a chance of having a child with out the genetic disease.
Article Details
Keywords
PGT-M, pyruvate kinase deficiency, PKLR
References
2. Genetic Testing Information. PKLR pyruvate kinase L/R [Homo sapiens (human)]. Retrieved May 03, 2025 from https://www.ncbi.nlm.nih.gov/ gene/5313/
3. Grace RF, Layton DM, Barcellini W. How we manage patients with pyruvate kinase deficiency. Br J Haematol. 2019;184(5):721-734
4. Wang X, Gardner K, Tegegn M B, et al. Genetic variants of PKLR are associated with acute pain in sickle cell disease. Blood Adv. 2022; 6(11): 3535-3540
5. Rakmanotham A, Sosothikul D, Techavichit P, Lauhasurayotin S, Chiengthong K, Poparn H. Pyruvate Kinase Deficiency presented with Severe Anemia and Jaundice. J Hematol Transfus Med Vol. 2021; 4(31):369-376
6. Wei DC, Chan LC, Li A. Homozygous pyruvate kinase deficiency in Hong Kong ethnic minorities. J Paediatr Child Health. 1992; 28:334–336.
7. Liu PP, Ding HQ, Huang SZ , Yang SY , Liu T. Severe congenital hemolytic anemia caused by a novel compound heterozygous PKLR gene mutation in a Chinese boy. Chin Med J (Engl). 2019;132(1):92–95.
8. So CC, Tang M, Li CH, Ha SY, Pissard S, Chan LC. First reported case of prenatal diagnosis for pyruvate kinase deficiency in a Chinese family. Hematology. 2011;16(6):377-9
9. Costa C, Albuisson J, Le TH, Max-Audit I, Dinh KT, Tosi M, et al. Severe hemolytic anemia in a Vietnamese family, associated with novel mutations in the gene encoding for pyruvate kinase. Haematologica. 2005; 90(1):25–30.
10. ESHRE PGT-M Working Group; Carvalho F , Moutou C , Dimitriadou E , Dreesen J , Giménez C , Goossens V , Kakourou G, Vermeulen N , Zuccarello D, Rycke MD. ESHRE PGT Consortium good practice recommendations for the detection of monogenic disorders. Hum Reprod Open. 2020;(3): hoaa018.